{"gene":"KLRC1","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1991,"finding":"KLRC1 (NKG2-A) encodes a type II integral membrane protein with a C-type lectin domain expressed on NK cells; NKG2-A and NKG2-B are alternative splicing products of a single gene (KLRC1).","method":"cDNA library screening, full-length cDNA sequencing, structural domain analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — original molecular cloning with full sequence analysis, foundational paper with 389 citations","pmids":["2007850"],"is_preprint":false},{"year":1996,"finding":"NKG2A (KLRC1) forms disulfide-bonded heterodimers with CD94 on the NK cell surface; NKG2A/B possesses two immunoreceptor tyrosine-based inhibition motifs (ITIMs) in its cytoplasmic domain, providing the molecular basis for inhibitory function.","method":"Co-immunoprecipitation, biochemical characterization, sequence analysis of ITIM motifs","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal co-IP demonstrating heterodimer, replicated across multiple labs, 352 citations","pmids":["8943374"],"is_preprint":false},{"year":1997,"finding":"The CD94/NKG2-A inhibitory receptor complex (where NKG2-A is encoded by KLRC1) is formed by covalent association of CD94 with NKG2-A (~43 kDa); NKG2-B, the alternatively spliced product, also assembles with CD94. Both contain cytoplasmic ITIMs providing molecular basis for inhibitory function.","method":"Immunoprecipitation with anti-CD94 and NKG2-A-specific mAb (Z199), biochemical characterization","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal immunoprecipitation identifying the complex, replicated findings, 250 citations","pmids":["9045931"],"is_preprint":false},{"year":1997,"finding":"NKG2-A (KLRC1) cytoplasmic domain delivers inhibitory signals to NK cells, while NKG2-C delivers activating signals; the inhibitory function of NKG2-A is mediated through selective recruitment of the tyrosine phosphatase SHP-1 to the NKG2-A/NKR-P1C chimeric receptor.","method":"Chimeric receptor transfection into RNK-16 NK cell line, cytolytic activity assay, calcium mobilization assay, immunoprecipitation of SHP-1","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — chimeric receptor functional assay plus SHP-1 co-IP, replicated, 186 citations","pmids":["9103421"],"is_preprint":false},{"year":1998,"finding":"CD94/NKG2-A (KLRC1) specifically recognizes HLA-E complexed with peptides derived from HLA class I signal sequences; only peptides containing Met at position 2 (residue 4 of the signal sequence) confer resistance to NK-mediated lysis through CD94/NKG2-A recognition.","method":"NK cytotoxicity assays with synthetic peptides, antibody blocking with CD94-specific and KIR-specific mAbs, HLA-E surface upregulation assay","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — direct functional assay with antibody blocking and peptide structure-function analysis, 567 citations","pmids":["9480992"],"is_preprint":false},{"year":1998,"finding":"Specific engagement of CD94/NKG2-A (KLRC1) by HLA-E or by anti-NKG2-A mAb induces tyrosine phosphorylation of the NKG2-A subunit and recruitment of SHP-1 phosphatase; this signaling cascade constitutes the molecular mechanism of CD94/NKG2-A-mediated inhibition.","method":"mAb cross-linking, Western blot for tyrosine phosphorylation, co-immunoprecipitation of SHP-1, transfection into RBL-2H3 cells, inhibition of Fc-epsilon-RI secretory events","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including phosphorylation, co-IP, heterologous transfection, and functional inhibition, 101 citations","pmids":["9565368"],"is_preprint":false},{"year":1998,"finding":"HLA-E-bound peptides influence recognition by inhibitory CD94/NKG2-A (KLRC1) and activating CD94/NKG2-C receptors; the HLA-G-derived nonamer peptide (VMAPRTLFL) engages the activating CD94/NKG2C receptor with significantly higher affinity than the inhibitory CD94/NKG2-A, triggering cytotoxicity.","method":"NK clone cytotoxicity assays with 721.221 cells loaded with synthetic leader sequence nonapeptides, HLA-E surface expression analysis","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — systematic peptide panel with NK clones expressing defined receptor isoforms, 311 citations","pmids":["9754572"],"is_preprint":false},{"year":1999,"finding":"CD94/NKG2-A (KLRC1) has higher binding affinity for HLA-E than the activating CD94/NKG2-C receptor; binding kinetics show very fast association and dissociation rate constants; recognition of HLA-E by both receptors is peptide-dependent with a direct correlation between binding affinity and NK cell response.","method":"Surface plasmon resonance (BIAcore) with soluble recombinant HLA-E and CD94/NKG2-A and CD94/NKG2-C proteins","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — quantitative binding kinetics with recombinant proteins, rigorous biophysical assay, 298 citations","pmids":["10428963"],"is_preprint":false},{"year":1999,"finding":"CD94/NKG2-A (KLRC1) inhibitory complex blocks CD16-triggered Syk kinase activation, tyrosine phosphorylation of CD16 zeta subunit, and downstream ERK activation in NK cells; the block operates at a PTK-dependent step by impairing Shc phosphorylation and Shc/Grb-2 complex formation.","method":"Co-engagement of CD94/NKG2-A and CD16 by antibody cross-linking, Western blot for Syk and ERK phosphorylation, Shc/Grb-2 co-immunoprecipitation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple signaling pathway components analyzed with orthogonal biochemical assays","pmids":["10358164"],"is_preprint":false},{"year":1999,"finding":"CD94/NKG2-A (KLRC1) engagement with HLA-E leads to phosphorylation of the CD94/NKG2 complex and recruitment of SHP-1 to the complex, mediating inhibition of xenoreactive NK cells.","method":"Antibody blocking assays with F(ab')2 anti-CD94, phosphorylation assay, SHP-1 co-immunoprecipitation in porcine endothelial cell model","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical confirmation of SHP-1 recruitment in a xenogeneic system, single lab","pmids":["10570324"],"is_preprint":false},{"year":1999,"finding":"The crystal structure of CD94 reveals a novel C-type lectin fold with a non-functional Ca2+-binding site and altered putative carbohydrate-binding site; the CD94 dimer interface reveals a putative HLA-E ligand-binding region and suggests how NKG2 interacts with CD94.","method":"X-ray crystallography at 2.6 Å resolution","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — crystal structure, foundational structural paper, 111 citations","pmids":["10023772"],"is_preprint":false},{"year":2000,"finding":"CD94/NKG2-A (KLRC1) co-engagement inhibits CD69-triggered ERK activation and NK cell degranulation; specifically, CD94/NKG2-A suppresses ERK activity initiated by CD69, providing molecular evidence for cross-inhibition between activating and inhibitory receptor pathways.","method":"RBL cell transfectants expressing both CD69 and CD94/NKG2-A, degranulation assay, ERK phosphorylation Western blot, cytotoxicity assay with anti-NKG2-A blockade","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic signaling assay in transfectants plus primary NK cell confirmation, multiple orthogonal methods","pmids":["10671222"],"is_preprint":false},{"year":2000,"finding":"CD94/NKG2-C (activating isoform) transduces its triggering signal through the DAP12/KARAP ITAM-bearing adaptor molecule; engagement of CD94/NKG2-C induces MAPK phosphorylation, and the MAPK pathway participates in CD94-dependent TNF-alpha production and cytotoxicity.","method":"NK clone activation assays, MEK inhibitor (PD098059), RBL transfection with CD94/NKG2-C/DAP12, calcium mobilization, serotonin release, MAPK phosphorylation","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — heterologous transfection plus pharmacological inhibition with multiple functional readouts","pmids":["11069065"],"is_preprint":false},{"year":2007,"finding":"The 2.5 Å crystal structure of CD94-NKG2A heterodimer shows an asymmetric dimer interface that contrasts with homodimeric NK receptors, providing a structural basis for preferred heterodimeric assembly; mutagenesis studies identify CD94 as playing the dominant role in interacting with HLA-E compared to the NKG2A chain.","method":"X-ray crystallography at 2.5 Å resolution, structure-based mutagenesis of HLA-E and CD94-NKG2A binding interface","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis validation, 81 citations","pmids":["18083576"],"is_preprint":false},{"year":2008,"finding":"Subtle changes in peptide conformation within the HLA-E binding groove—not changes in HLA-E heavy chain conformation—determine differential recognition by CD94-NKG2 receptors; structural comparison of HLA-E/VMAPRALLL (poorly recognized) vs HLA-E/VMAPRTLFL (high affinity CD94-NKG2 ligand) revealed peptide conformation as the discriminating feature.","method":"X-ray crystallography of HLA-E/peptide complexes at 2.5 Å resolution","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — dual crystal structures with direct structural comparison, 88 citations","pmids":["18339401"],"is_preprint":false},{"year":1997,"finding":"CD94/NKG2-A (KLRC1) inhibitory receptor is involved in NK cell recognition of HLA-G1; mAbs against CD94 reconstituted cytolytic activity against HLA-G1-transfected cells, and most NK clones inhibited by HLA-G1 expressed CD94/NKG2-A.","method":"NK clone cytotoxicity assays, antibody blocking with CD94- and KIR-specific mAbs, KIR-IgG fusion protein binding assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct functional assay with specific antibody blocking, replicated across donors, 109 citations","pmids":["9190923"],"is_preprint":false},{"year":1997,"finding":"CD94/NKG2-A (KLRC1) is the predominant inhibitory NK receptor for HLA-G used by decidual NK cells; anti-CD94 mAb prevented NK cell recognition of HLA-G transfectants, whereas mAbs against KIR receptors for HLA-C and HLA-B had no effect.","method":"NK clone cytotoxicity assays with 721.221 cells transfected with HLA-G, mAb blocking with anti-CD94 and anti-KIR antibodies","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — specific antibody blocking in primary decidual NK clones, 95 citations","pmids":["9233599"],"is_preprint":false},{"year":2000,"finding":"HLA-E is expressed on trophoblast cells, and CD94/NKG2-A (KLRC1) on decidual NK cells binds HLA-E tetrameric complexes; the overall effect of CD94/NKG2 interaction with HLA-E is inhibition of cytotoxicity by decidual NK cells.","method":"HLA-E tetramer binding assays, antibody blocking with anti-CD94, cytotoxicity assays with decidual NK cells","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct tetramer binding plus functional cytotoxicity assay with blocking, 290 citations","pmids":["10898498"],"is_preprint":false},{"year":1997,"finding":"CD94/NKG2-A (KLRC1) inhibitory receptor modulates anti-viral and anti-tumoral responses of Vgamma9Vdelta2 T cells; anti-CD94 mAb inhibits Vgamma9Vdelta2 T cell proliferation, IFN-gamma and TNF-alpha synthesis, and cytotoxic activity.","method":"Cytokine production assays, proliferation assays, cytotoxicity assays with anti-CD94 mAb blocking","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional blocking assay but indirect (antibody against CD94 subunit), single lab, 129 citations","pmids":["9550399"],"is_preprint":false},{"year":2004,"finding":"In the absence of DAP12, NKG2A (KLRC1) is preferentially expressed at the cell surface with CD94 over NKG2C due to a single amino acid difference in the transmembrane domain; DAP12 co-expression enhances NKG2C's ability to compete for cell surface CD94 heterodimerization.","method":"Transfection of rhesus monkey NKG2A and NKG2C into COS cells with and without DAP12, flow cytometry for cell surface expression, chimeric receptor constructs","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — transfection-based mapping of transmembrane domain determinants for heterodimerization, single lab","pmids":["15153509"],"is_preprint":false},{"year":2005,"finding":"The CD94/NKG2A (KLRC1) inhibitory receptor plays a critical role in down-regulating iNKT cell responses; IFN-gamma upregulates Qa-1b (murine HLA-E homolog) expression which in turn inhibits iNKT cell activity via CD94/NKG2A interaction; blockade of CD94/NKG2-Qa-1b interaction augments recall responses.","method":"Mouse iNKT cell stimulation with alpha-GalCer/OCH, antibody blockade of CD94/NKG2 interaction, cytokine measurement, genetic epistasis with Qa-1b","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — functional epistasis with blocking antibody in mouse model, 45 citations","pmids":["15746081"],"is_preprint":false},{"year":2002,"finding":"IL-12 induces expression of NKG2-A (KLRC1) and CD94 on CD8+ T cells, and IL-12-induced expression of both subunits leads to acquisition of a functional inhibitory receptor as demonstrated in redirected killing assays; this induction was not mediated by IFN-gamma or IL-15.","method":"Cytokine stimulation of T cells, flow cytometry, redirected killing assay, RT-PCR","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — cytokine induction coupled to functional receptor assay, single lab, 57 citations","pmids":["11994435"],"is_preprint":false},{"year":2022,"finding":"CD94/NKG2 (KLRC1 product) expressed on microglial cells interacts with Qa-1 (murine HLA-E homolog) expressed in layer 6 cortical neurons to regulate activity-dependent ocular dominance plasticity; selectively targeting the Qa-1/CD94/NKG2 interaction phenocopies plasticity perturbation seen in Qa-1 knockout mice.","method":"Mouse genetic knockout (Qa-1 KO), pharmacological blockade of Qa-1/CD94-NKG2 interaction, ocular dominance plasticity assay, microglial morphology analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO combined with receptor blockade establishing functional pathway in a novel cellular context, 12 citations","pmids":["35648829"],"is_preprint":false},{"year":2023,"finding":"KLRC1 knockout in human NK cells eliminates NKG2A surface expression and overcomes HLA-E-mediated inhibition of NK cytotoxicity against solid tumor cell lines; KLRC1 KO NK cells showed significantly higher cytotoxicity against HLA-E+ tumor lines and delayed tumor progression in a xenograft mouse model; NKG2C expression was increased in KLRC1 KO NK cells.","method":"CRISPR-mediated KLRC1 gene editing, in vitro cytotoxicity assays against multiple tumor lines, xenogeneic mouse model of HLA-E+ metastatic breast cancer","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined phenotypic readout in vitro and in vivo, multiple tumor lines tested","pmids":["37675109"],"is_preprint":false},{"year":2024,"finding":"LAG-3 sustains a CD94/NKG2+ subset of exhausted CD8 T cells with enhanced cytotoxicity mediated by recognition of the stress ligand Qa-1b; loss of LAG-3 reduces this CD94/NKG2+ Tex subset, demonstrating a LAG-3-dependent circuit for NKG2 expression in T cell exhaustion.","method":"Genetic loss-of-function (LAG-3 KO), chronic viral infection mouse model, single-cell analysis, in vitro functional assays with Qa-1b blocking","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis plus functional validation in vivo and in vitro, 76 citations","pmids":["39121847"],"is_preprint":false},{"year":2023,"finding":"Antigen-specific NK cell memory against HIV and influenza is largely dependent on the activating CD94/NKG2C receptor and its ligand HLA-E; individual memory NK cells permanently acquired antigen specificity (validated by single-cell cloning), and individual HLA-E-restricted peptides constitute dominant NK cell responses in vivo.","method":"Single-cell cloning of memory NK cells, complex immunophenotyping, HLA-E peptide stimulation assays, functional memory assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — single-cell cloning with functional validation establishing antigen specificity via CD94/NKG2C-HLA-E axis","pmids":["38064568"],"is_preprint":false},{"year":2023,"finding":"Among 16 common classical HLA class I signal peptide (SP) variants, only 6 'functional SPs' efficiently generate epitopes enabling CD94/NKG2 engagement with HLA-E; HLA-B/-21M SP induces high HLA-E expression but provides the lowest receptor recognition and competes with other SPs, reducing overall CD94/NKG2A recognition of target cells.","method":"Systematic quantitative peptide-HLA-E binding assays, CD94/NKG2 receptor recognition functional assays, genetic population analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — systematic quantitative approach with multiple orthogonal functional assays, 49 citations","pmids":["37264229"],"is_preprint":false}],"current_model":"KLRC1 encodes NKG2A, which forms a disulfide-linked heterodimer with CD94 on NK and T cells; this CD94/NKG2A complex functions as an inhibitory receptor that recognizes HLA-E loaded with HLA class I signal sequence-derived nonapeptides, triggering ITIM-mediated recruitment of SHP-1 phosphatase to tyrosine-phosphorylated NKG2A, which then blocks downstream Syk and ERK activation to suppress NK cytotoxicity, while the activating paralogue NKG2C (in the CD94/NKG2C heterodimer coupled to DAP12) delivers opposite signals—with CD94 playing the dominant role in HLA-E contact as revealed by crystal structures of the CD94-NKG2A/HLA-E axis."},"narrative":{"teleology":[{"year":1991,"claim":"Molecular cloning established that KLRC1 encodes a novel NK-cell-expressed type II membrane protein with a C-type lectin domain, revealing the gene's identity and basic structural architecture.","evidence":"cDNA library screening and full-length sequencing from an NK cell line","pmids":["2007850"],"confidence":"High","gaps":["Ligand unknown","Signaling function unknown","Heterodimeric partner not yet identified"]},{"year":1996,"claim":"Biochemical studies revealed that NKG2A obligately heterodimerizes with CD94 via disulfide bonds and that its cytoplasmic ITIMs provide the structural basis for inhibitory signaling, resolving how the receptor complex assembles and predicting its inhibitory function.","evidence":"Reciprocal co-immunoprecipitation and ITIM motif identification across multiple labs","pmids":["8943374","9045931"],"confidence":"High","gaps":["Ligand identity still unknown","ITIM-dependent phosphatase recruitment not yet demonstrated"]},{"year":1997,"claim":"Chimeric receptor assays and functional studies identified SHP-1 phosphatase recruitment to phosphorylated NKG2A as the proximal mechanism of inhibition, and demonstrated that HLA-E (loaded with HLA class I signal peptides) is the ligand—with CD94/NKG2A also mediating inhibition of decidual NK killing of HLA-G-expressing trophoblast via HLA-E.","evidence":"Chimeric receptor transfection with SHP-1 co-IP; NK cytotoxicity assays with synthetic peptides and anti-CD94 blocking; decidual NK clone assays","pmids":["9103421","9480992","9190923","9233599"],"confidence":"High","gaps":["Quantitative binding affinity not measured","Structural basis of HLA-E recognition unknown","Downstream signaling cascade beyond SHP-1 not mapped"]},{"year":1998,"claim":"Ligand engagement was shown to induce NKG2A tyrosine phosphorylation and SHP-1 recruitment in intact cells, confirming the ITIM→SHP-1 model; peptide selectivity studies revealed that peptide conformation within HLA-E governs differential recognition by inhibitory NKG2A versus activating NKG2C.","evidence":"Cross-linking, phosphorylation assays, heterologous RBL transfectants; NK clones with systematic peptide panels","pmids":["9565368","9754572"],"confidence":"High","gaps":["Binding kinetics not quantified","No structural explanation for peptide discrimination"]},{"year":1999,"claim":"Biophysical measurements established that CD94/NKG2A binds HLA-E with higher affinity than CD94/NKG2C, explaining how the inhibitory receptor dominates under physiological conditions; signaling studies mapped the downstream inhibitory cascade to blockade of Syk, ERK, and Shc/Grb-2 pathways.","evidence":"Surface plasmon resonance with recombinant proteins; antibody co-crosslinking with Western blot for Syk, ERK, Shc phosphorylation","pmids":["10428963","10358164","10023772"],"confidence":"High","gaps":["No co-crystal of CD94/NKG2A with HLA-E","Structural basis for affinity difference between NKG2A and NKG2C unclear"]},{"year":2000,"claim":"CD94/NKG2A was shown to cross-inhibit activating receptors including CD69-triggered ERK signaling, and HLA-E tetramer binding confirmed the pathway operates in decidual NK cells to maintain fetal tolerance.","evidence":"RBL transfectants co-expressing CD69 and CD94/NKG2A with ERK and degranulation assays; HLA-E tetramer staining of decidual NK cells","pmids":["10671222","10898498"],"confidence":"High","gaps":["Relative contribution of CD94/NKG2A versus KIR to maternal-fetal tolerance not resolved","In vivo relevance in human pregnancy not tested"]},{"year":2004,"claim":"Transmembrane domain determinants were found to explain preferential surface expression of NKG2A over NKG2C in the absence of DAP12, providing a mechanism for default inhibitory bias at the cell surface.","evidence":"Transfection of NKG2A/NKG2C chimeras into COS cells ± DAP12, flow cytometry","pmids":["15153509"],"confidence":"Medium","gaps":["Study used rhesus monkey sequences; human equivalence assumed but not directly tested","Quantitative stoichiometry on primary human NK cells not determined"]},{"year":2007,"claim":"The crystal structure of the CD94–NKG2A heterodimer revealed an asymmetric interface and mutagenesis identified CD94 as the dominant HLA-E-contacting subunit, answering how the two chains divide labor in ligand recognition.","evidence":"X-ray crystallography at 2.5 Å with structure-guided mutagenesis","pmids":["18083576"],"confidence":"High","gaps":["Full ternary complex structure (CD94/NKG2A bound to HLA-E/peptide) not yet solved at this point","How NKG2A ITIM accessibility changes upon ligand binding structurally unresolved"]},{"year":2008,"claim":"Comparative crystallography of HLA-E with different peptides showed that subtle peptide conformational changes—not HLA-E heavy chain rearrangements—govern differential CD94/NKG2 recognition, explaining peptide-dependent selectivity at atomic resolution.","evidence":"Dual crystal structures of HLA-E/peptide complexes at 2.5 Å","pmids":["18339401"],"confidence":"High","gaps":["Ternary complex with receptor still not captured crystallographically","Dynamic aspects of peptide-dependent discrimination not addressed"]},{"year":2022,"claim":"The Qa-1/CD94/NKG2 axis was discovered to operate in microglia regulating neuronal ocular dominance plasticity, extending the receptor's functional role far beyond classical immune surveillance.","evidence":"Qa-1 knockout mice and pharmacological blockade of CD94/NKG2 in ocular dominance plasticity assays","pmids":["35648829"],"confidence":"Medium","gaps":["Human relevance not established","Whether this involves NKG2A (inhibitory) or NKG2C (activating) signaling in microglia not distinguished","Downstream microglial effector mechanisms unknown"]},{"year":2023,"claim":"CRISPR knockout of KLRC1 in human NK cells eliminated HLA-E-mediated inhibition and enhanced anti-tumor cytotoxicity in vivo, validating NKG2A as a non-redundant immune checkpoint; concurrently, systematic analysis of HLA class I signal peptides showed only 6 of 16 variants efficiently engage CD94/NKG2A through HLA-E, revealing population-level heterogeneity in checkpoint strength.","evidence":"KLRC1 CRISPR KO NK cells in xenograft breast cancer model; quantitative peptide-HLA-E binding and receptor recognition assays across 16 signal peptide variants","pmids":["37675109","37264229"],"confidence":"High","gaps":["Clinical translation of KLRC1 KO NK cell therapy not validated","How signal peptide competition shapes individual immune responses in vivo not fully modeled"]},{"year":2024,"claim":"LAG-3 was found to sustain a CD94/NKG2-expressing subset of exhausted CD8+ T cells with enhanced cytotoxicity via Qa-1b recognition, revealing a regulatory circuit that links T cell exhaustion programs to NKG2 receptor expression.","evidence":"LAG-3 KO in chronic LCMV infection model with single-cell profiling and Qa-1b blocking","pmids":["39121847"],"confidence":"High","gaps":["Whether LAG-3 regulates NKG2A versus NKG2C specifically in this context not resolved","Human correlate of LAG-3/NKG2 axis in chronic infection or cancer not demonstrated"]},{"year":null,"claim":"Key unresolved questions include the full ternary crystal structure of CD94/NKG2A bound to HLA-E/peptide, the conformational dynamics linking ligand engagement to ITIM phosphorylation, how NKG2A versus NKG2C expression is regulated at the transcriptional level in different lymphocyte subsets, and whether the neuroimmune functions of this axis operate through canonical ITIM/SHP-1 signaling.","evidence":"","pmids":[],"confidence":"Low","gaps":["No ternary co-crystal structure of CD94/NKG2A/HLA-E/peptide published","Transcriptional regulation of KLRC1 in different cell lineages poorly defined","Mechanism of NKG2A function in microglia not molecularly characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,3,5,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,8,11]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,19]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,4,5,8,11,23,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,5,8,11,12]}],"complexes":["CD94/NKG2A heterodimer"],"partners":["CD94","SHP-1","HLA-E","DAP12","NKG2C","LAG-3"],"other_free_text":[]},"mechanistic_narrative":"KLRC1 encodes NKG2A, a type II transmembrane C-type lectin-domain protein that forms a disulfide-linked inhibitory heterodimer with CD94 on NK cells, CD8+ T cells, γδ T cells, and iNKT cells, serving as a central checkpoint receptor that monitors HLA class I expression through recognition of HLA-E loaded with signal-sequence-derived nonapeptides [PMID:2007850, PMID:8943374, PMID:9480992]. Ligand engagement induces tyrosine phosphorylation of the NKG2A ITIM motifs and recruitment of the SHP-1 phosphatase, which blocks proximal signaling through Syk, ERK, and Shc/Grb-2, thereby suppressing cytotoxicity and cytokine production [PMID:9103421, PMID:9565368, PMID:10358164]. The CD94/NKG2A heterodimer binds HLA-E with higher affinity than its activating counterpart CD94/NKG2C, with peptide conformation within the HLA-E groove—rather than heavy-chain differences—determining differential receptor engagement, and CD94 contributing the dominant ligand-contact surface as revealed by crystal structures [PMID:10428963, PMID:18083576, PMID:18339401]. Beyond canonical immune surveillance, this receptor axis operates in decidual NK cell tolerance to trophoblast HLA-E, in LAG-3-dependent exhausted CD8+ T cell subsets during chronic viral infection, and in microglial regulation of ocular dominance plasticity [PMID:10898498, PMID:39121847, PMID:35648829]."},"prefetch_data":{"uniprot":{"accession":"P26715","full_name":"NKG2-A/NKG2-B type II integral membrane protein","aliases":["CD159 antigen-like family member A","NK cell receptor A","NKG2-A/B-activating NK receptor"],"length_aa":233,"mass_kda":26.3,"function":"Immune inhibitory receptor involved in self-nonself discrimination. In complex with KLRD1 on cytotoxic and regulatory lymphocyte subsets, recognizes non-classical major histocompatibility (MHC) class Ib molecule HLA-E loaded with self-peptides derived from the signal sequence of classical MHC class Ia molecules. Enables cytotoxic cells to monitor the expression of MHC class I molecules in healthy cells and to tolerate self (PubMed:18083576, PubMed:37264229, PubMed:9430220, PubMed:9486650). Upon HLA-E-peptide binding, transmits intracellular signals through two immunoreceptor tyrosine-based inhibition motifs (ITIMs) by recruiting INPP5D/SHP-1 and INPPL1/SHP-2 tyrosine phosphatases to ITIMs, and ultimately opposing signals transmitted by activating receptors through dephosphorylation of proximal signaling molecules (PubMed:12165520, PubMed:9485206). Key inhibitory receptor on natural killer (NK) cells that regulates their activation and effector functions (PubMed:30860984, PubMed:9430220, PubMed:9485206, PubMed:9486650). Dominantly counteracts T cell receptor signaling on a subset of memory/effector CD8-positive T cells as part of an antigen-driven response to avoid autoimmunity (PubMed:12387742). On intraepithelial CD8-positive gamma-delta regulatory T cells triggers TGFB1 secretion, which in turn limits the cytotoxic programming of intraepithelial CD8-positive alpha-beta T cells, distinguishing harmless from pathogenic antigens (PubMed:18064301). In HLA-E-rich tumor microenvironment, acts as an immune inhibitory checkpoint and may contribute to progressive loss of effector functions of NK cells and tumor-specific T cells, a state known as cell exhaustion (PubMed:30503213, PubMed:30860984) (Microbial infection) Viruses like human cytomegalovirus have evolved an escape mechanism whereby virus-induced down-regulation of host MHC class I molecules is coupled to the binding of viral peptides to HLA-E, restoring HLA-E expression and inducing HLA-E-dependent NK cell immune tolerance to infected cells. Recognizes HLA-E in complex with human cytomegalovirus UL40-derived peptide (VMAPRTLIL) and inhibits NK cell cytotoxicity (Microbial infection) May recognize HLA-E in complex with HIV-1 gag/Capsid protein p24-derived peptide (AISPRTLNA) on infected cells and may inhibit NK cell cytotoxicity, a mechanism that allows HIV-1 to escape immune recognition (Microbial infection) Upon SARS-CoV-2 infection, may contribute to functional exhaustion of cytotoxic NK cells and CD8-positive T cells (PubMed:32203188, PubMed:32859121). On NK cells, may recognize HLA-E in complex with SARS-CoV-2 S/Spike protein S1-derived peptide (LQPRTFLL) expressed on the surface of lung epithelial cells, inducing NK cell exhaustion and dampening antiviral immune surveillance (PubMed:32859121)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P26715/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KLRC1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KLRC1","total_profiled":1310},"omim":[{"mim_id":"606782","title":"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A","url":"https://www.omim.org/entry/606782"},{"mim_id":"605029","title":"KILLER CELL LECTIN-LIKE RECEPTOR F1; KLRF1","url":"https://www.omim.org/entry/605029"},{"mim_id":"602992","title":"LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; LAIR1","url":"https://www.omim.org/entry/602992"},{"mim_id":"161555","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1","url":"https://www.omim.org/entry/161555"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":6.2}],"url":"https://www.proteinatlas.org/search/KLRC1"},"hgnc":{"alias_symbol":["NKG2-A","NKG2-B","CD159a"],"prev_symbol":["NKG2"]},"alphafold":{"accession":"P26715","domains":[{"cath_id":"3.10.100.10","chopping":"138-147_159-228","consensus_level":"high","plddt":94.8103,"start":138,"end":228}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26715","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26715-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26715-F1-predicted_aligned_error_v6.png","plddt_mean":75.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KLRC1","jax_strain_url":"https://www.jax.org/strain/search?query=KLRC1"},"sequence":{"accession":"P26715","fasta_url":"https://rest.uniprot.org/uniprotkb/P26715.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26715/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26715"}},"corpus_meta":[{"pmid":"9480992","id":"PMC_9480992","title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9480992","citation_count":567,"is_preprint":false},{"pmid":"2007850","id":"PMC_2007850","title":"DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2007850","citation_count":389,"is_preprint":false},{"pmid":"8943374","id":"PMC_8943374","title":"Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8943374","citation_count":352,"is_preprint":false},{"pmid":"9754572","id":"PMC_9754572","title":"HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9754572","citation_count":311,"is_preprint":false},{"pmid":"10428963","id":"PMC_10428963","title":"Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10428963","citation_count":298,"is_preprint":false},{"pmid":"10898498","id":"PMC_10898498","title":"HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10898498","citation_count":290,"is_preprint":false},{"pmid":"9045931","id":"PMC_9045931","title":"The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9045931","citation_count":250,"is_preprint":false},{"pmid":"9103421","id":"PMC_9103421","title":"Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9103421","citation_count":186,"is_preprint":false},{"pmid":"9209487","id":"PMC_9209487","title":"Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9209487","citation_count":138,"is_preprint":false},{"pmid":"9550399","id":"PMC_9550399","title":"CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9550399","citation_count":129,"is_preprint":false},{"pmid":"17172651","id":"PMC_17172651","title":"The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.","date":"2006","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/17172651","citation_count":118,"is_preprint":false},{"pmid":"10023772","id":"PMC_10023772","title":"Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10023772","citation_count":111,"is_preprint":false},{"pmid":"9190923","id":"PMC_9190923","title":"The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9190923","citation_count":109,"is_preprint":false},{"pmid":"9565368","id":"PMC_9565368","title":"Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9565368","citation_count":101,"is_preprint":false},{"pmid":"15258309","id":"PMC_15258309","title":"The role of CD94/NKG2 in innate and adaptive immunity.","date":"2004","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/15258309","citation_count":98,"is_preprint":false},{"pmid":"9233599","id":"PMC_9233599","title":"CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9233599","citation_count":95,"is_preprint":false},{"pmid":"9485212","id":"PMC_9485212","title":"The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9485212","citation_count":93,"is_preprint":false},{"pmid":"18339401","id":"PMC_18339401","title":"Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18339401","citation_count":88,"is_preprint":false},{"pmid":"18083576","id":"PMC_18083576","title":"The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.","date":"2007","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18083576","citation_count":81,"is_preprint":false},{"pmid":"16227783","id":"PMC_16227783","title":"Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy.","date":"2005","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16227783","citation_count":81,"is_preprint":false},{"pmid":"21800130","id":"PMC_21800130","title":"Clinical significance of the HLA-E and CD94/NKG2 interaction.","date":"2011","source":"Archivum immunologiae et therapiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/21800130","citation_count":80,"is_preprint":false},{"pmid":"39121847","id":"PMC_39121847","title":"LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity.","date":"2024","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/39121847","citation_count":76,"is_preprint":false},{"pmid":"30984204","id":"PMC_30984204","title":"NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30984204","citation_count":75,"is_preprint":false},{"pmid":"11751968","id":"PMC_11751968","title":"Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11751968","citation_count":71,"is_preprint":false},{"pmid":"10671222","id":"PMC_10671222","title":"CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10671222","citation_count":59,"is_preprint":false},{"pmid":"11994435","id":"PMC_11994435","title":"Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11994435","citation_count":57,"is_preprint":false},{"pmid":"15829421","id":"PMC_15829421","title":"Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells.","date":"2005","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15829421","citation_count":55,"is_preprint":false},{"pmid":"10570324","id":"PMC_10570324","title":"HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10570324","citation_count":51,"is_preprint":false},{"pmid":"38064568","id":"PMC_38064568","title":"Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axis.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38064568","citation_count":49,"is_preprint":false},{"pmid":"37264229","id":"PMC_37264229","title":"HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37264229","citation_count":49,"is_preprint":false},{"pmid":"9394807","id":"PMC_9394807","title":"Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9394807","citation_count":49,"is_preprint":false},{"pmid":"11254682","id":"PMC_11254682","title":"Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11254682","citation_count":47,"is_preprint":false},{"pmid":"11907085","id":"PMC_11907085","title":"Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11907085","citation_count":47,"is_preprint":false},{"pmid":"12618865","id":"PMC_12618865","title":"Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population.","date":"2003","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12618865","citation_count":46,"is_preprint":false},{"pmid":"15746081","id":"PMC_15746081","title":"IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15746081","citation_count":45,"is_preprint":false},{"pmid":"9521051","id":"PMC_9521051","title":"Two genes in the rat homologous to human NKG2.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9521051","citation_count":45,"is_preprint":false},{"pmid":"11782245","id":"PMC_11782245","title":"The KIR and CD94/NKG2 families of molecules in the rhesus monkey.","date":"2001","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11782245","citation_count":44,"is_preprint":false},{"pmid":"11513155","id":"PMC_11513155","title":"Ly49 and CD94/NKG2: developmentally regulated expression and evolution.","date":"2001","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11513155","citation_count":42,"is_preprint":false},{"pmid":"10358164","id":"PMC_10358164","title":"CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10358164","citation_count":37,"is_preprint":false},{"pmid":"11994449","id":"PMC_11994449","title":"Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11994449","citation_count":33,"is_preprint":false},{"pmid":"12097371","id":"PMC_12097371","title":"CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12097371","citation_count":33,"is_preprint":false},{"pmid":"37675109","id":"PMC_37675109","title":"KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37675109","citation_count":32,"is_preprint":false},{"pmid":"11870631","id":"PMC_11870631","title":"NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.","date":"2002","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11870631","citation_count":32,"is_preprint":false},{"pmid":"17505822","id":"PMC_17505822","title":"Chicken CD69 and CD94/NKG2-like genes in a chromosomal region syntenic to mammalian natural killer gene complex.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17505822","citation_count":31,"is_preprint":false},{"pmid":"12191515","id":"PMC_12191515","title":"Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones.","date":"2002","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/12191515","citation_count":31,"is_preprint":false},{"pmid":"9887346","id":"PMC_9887346","title":"Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex.","date":"1999","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9887346","citation_count":29,"is_preprint":false},{"pmid":"7589093","id":"PMC_7589093","title":"NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7589093","citation_count":28,"is_preprint":false},{"pmid":"11493613","id":"PMC_11493613","title":"Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation.","date":"2001","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/11493613","citation_count":28,"is_preprint":false},{"pmid":"20863413","id":"PMC_20863413","title":"Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.","date":"2010","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/20863413","citation_count":24,"is_preprint":false},{"pmid":"17462078","id":"PMC_17462078","title":"Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17462078","citation_count":24,"is_preprint":false},{"pmid":"10771475","id":"PMC_10771475","title":"Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.","date":"2000","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10771475","citation_count":23,"is_preprint":false},{"pmid":"12421909","id":"PMC_12421909","title":"Cutting edge: CD94/NKG2 is expressed on Th1 but not Th2 cells and costimulates Th1 effector functions.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12421909","citation_count":23,"is_preprint":false},{"pmid":"11169413","id":"PMC_11169413","title":"Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11169413","citation_count":21,"is_preprint":false},{"pmid":"11197693","id":"PMC_11197693","title":"The NKG2 natural killer cell receptor family: comparative analysis of promoter sequences.","date":"2000","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11197693","citation_count":19,"is_preprint":false},{"pmid":"27565739","id":"PMC_27565739","title":"Diversification of both KIR and NKG2 natural killer cell receptor genes in macaques - implications for highly complex MHC-dependent regulation of natural killer cells.","date":"2016","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27565739","citation_count":19,"is_preprint":false},{"pmid":"16323414","id":"PMC_16323414","title":"NKG2 receptor-mediated regulation of effector CTL functions in the human tissue microenvironment.","date":"2006","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16323414","citation_count":19,"is_preprint":false},{"pmid":"17285285","id":"PMC_17285285","title":"Complexity in the cattle CD94/NKG2 gene families.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17285285","citation_count":18,"is_preprint":false},{"pmid":"31992596","id":"PMC_31992596","title":"The murine CD94/NKG2 ligand, Qa-1b, is a high-affinity, functional ligand for the CD8αα homodimer.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31992596","citation_count":16,"is_preprint":false},{"pmid":"15302848","id":"PMC_15302848","title":"Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.","date":"2004","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15302848","citation_count":14,"is_preprint":false},{"pmid":"11196705","id":"PMC_11196705","title":"The centromeric part of the human NK gene complex: linkage of LOX-1 and LY49L with the CD94/NKG2 region.","date":"2000","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11196705","citation_count":14,"is_preprint":false},{"pmid":"11918704","id":"PMC_11918704","title":"Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.","date":"2002","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11918704","citation_count":14,"is_preprint":false},{"pmid":"15153509","id":"PMC_15153509","title":"Molecular determinants regulating the pairing of NKG2 molecules with CD94 for cell surface heterodimer expression.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15153509","citation_count":13,"is_preprint":false},{"pmid":"11457486","id":"PMC_11457486","title":"Homologues of natural killer cell receptors NKG2-D and NKR-P1 expressed in cattle.","date":"2001","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/11457486","citation_count":13,"is_preprint":false},{"pmid":"26361968","id":"PMC_26361968","title":"Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.","date":"2015","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/26361968","citation_count":13,"is_preprint":false},{"pmid":"11069065","id":"PMC_11069065","title":"Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11069065","citation_count":13,"is_preprint":false},{"pmid":"9212363","id":"PMC_9212363","title":"The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules.","date":"1997","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/9212363","citation_count":12,"is_preprint":false},{"pmid":"15498028","id":"PMC_15498028","title":"Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys.","date":"2004","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15498028","citation_count":12,"is_preprint":false},{"pmid":"35648829","id":"PMC_35648829","title":"The nonclassical MHC class I Qa-1 expressed in layer 6 neurons regulates activity-dependent plasticity via microglial CD94/NKG2 in the cortex.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35648829","citation_count":12,"is_preprint":false},{"pmid":"11841384","id":"PMC_11841384","title":"A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion.","date":"2002","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11841384","citation_count":12,"is_preprint":false},{"pmid":"39815622","id":"PMC_39815622","title":"Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells.","date":"2025","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39815622","citation_count":10,"is_preprint":false},{"pmid":"39229258","id":"PMC_39229258","title":"A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39229258","citation_count":8,"is_preprint":false},{"pmid":"10817639","id":"PMC_10817639","title":"Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.","date":"2000","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/10817639","citation_count":8,"is_preprint":false},{"pmid":"15550116","id":"PMC_15550116","title":"Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses.","date":"2004","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15550116","citation_count":8,"is_preprint":false},{"pmid":"15827137","id":"PMC_15827137","title":"Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-beta receptor expression.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15827137","citation_count":8,"is_preprint":false},{"pmid":"10320637","id":"PMC_10320637","title":"Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.","date":"1999","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10320637","citation_count":7,"is_preprint":false},{"pmid":"35888169","id":"PMC_35888169","title":"Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35888169","citation_count":6,"is_preprint":false},{"pmid":"31320124","id":"PMC_31320124","title":"Haplotype block 1 variant (HB-1v) of the NKG2 family of receptors.","date":"2019","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31320124","citation_count":6,"is_preprint":false},{"pmid":"10488737","id":"PMC_10488737","title":"N-linked oligosaccharides can protect target cells from the lysis mediated by NK cells but not by cytotoxic T lymphocytes: role of NKG2-A.","date":"1999","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/10488737","citation_count":6,"is_preprint":false},{"pmid":"37901227","id":"PMC_37901227","title":"Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37901227","citation_count":5,"is_preprint":false},{"pmid":"37352688","id":"PMC_37352688","title":"Association between NKG2/KLR gene variants and epilepsy in Autism Spectrum Disorder.","date":"2023","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/37352688","citation_count":4,"is_preprint":false},{"pmid":"39798802","id":"PMC_39798802","title":"The Association of HLA-E Ligand and NKG2 Receptor Variation With Relapse and Mortality After Haploidentical Related Donor Transplantation.","date":"2025","source":"Transplantation and cellular therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39798802","citation_count":4,"is_preprint":false},{"pmid":"39401997","id":"PMC_39401997","title":"DNA Methylation of KLRC1 and KLRC3 in Autoimmune Thyroiditis: Perspective of Different Water Iodine Exposure.","date":"2024","source":"Biomedical and environmental sciences : BES","url":"https://pubmed.ncbi.nlm.nih.gov/39401997","citation_count":2,"is_preprint":false},{"pmid":"40683494","id":"PMC_40683494","title":"Molecular characterization and functional prioritization of CD46, IL6R, KLRC1, LEAP2 and SMOX as candidate targets in acute kidney injury.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40683494","citation_count":1,"is_preprint":false},{"pmid":"17896104","id":"PMC_17896104","title":"Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17896104","citation_count":1,"is_preprint":false},{"pmid":"17545086","id":"PMC_17545086","title":"[Identification of a novel candidate gene KLRC1 within the putative susceptibility locus for systemic lupus erythematosus at 12p12.3-13.2 in a Chinese cohort].","date":"2007","source":"Nan fang yi ke da xue xue bao = Journal of Southern Medical University","url":"https://pubmed.ncbi.nlm.nih.gov/17545086","citation_count":1,"is_preprint":false},{"pmid":"38405747","id":"PMC_38405747","title":"Virus-free CRISPR knock-in of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38405747","citation_count":0,"is_preprint":false},{"pmid":"41811633","id":"PMC_41811633","title":"Tumor-intrinsic KLRC1 exerts tumor-suppressive functions in colorectal cancer.","date":"2026","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41811633","citation_count":0,"is_preprint":false},{"pmid":"41153412","id":"PMC_41153412","title":"Genetic Variability in NKG2 Receptors and Their Ligands: Associations with SARS-CoV-2 Infection and COVID-19 Severity.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/41153412","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42259,"output_tokens":6332,"usd":0.110879},"stage2":{"model":"claude-opus-4-6","input_tokens":9970,"output_tokens":3235,"usd":0.196087},"total_usd":0.306966,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"KLRC1 (NKG2-A) encodes a type II integral membrane protein with a C-type lectin domain expressed on NK cells; NKG2-A and NKG2-B are alternative splicing products of a single gene (KLRC1).\",\n      \"method\": \"cDNA library screening, full-length cDNA sequencing, structural domain analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original molecular cloning with full sequence analysis, foundational paper with 389 citations\",\n      \"pmids\": [\"2007850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"NKG2A (KLRC1) forms disulfide-bonded heterodimers with CD94 on the NK cell surface; NKG2A/B possesses two immunoreceptor tyrosine-based inhibition motifs (ITIMs) in its cytoplasmic domain, providing the molecular basis for inhibitory function.\",\n      \"method\": \"Co-immunoprecipitation, biochemical characterization, sequence analysis of ITIM motifs\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal co-IP demonstrating heterodimer, replicated across multiple labs, 352 citations\",\n      \"pmids\": [\"8943374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The CD94/NKG2-A inhibitory receptor complex (where NKG2-A is encoded by KLRC1) is formed by covalent association of CD94 with NKG2-A (~43 kDa); NKG2-B, the alternatively spliced product, also assembles with CD94. Both contain cytoplasmic ITIMs providing molecular basis for inhibitory function.\",\n      \"method\": \"Immunoprecipitation with anti-CD94 and NKG2-A-specific mAb (Z199), biochemical characterization\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal immunoprecipitation identifying the complex, replicated findings, 250 citations\",\n      \"pmids\": [\"9045931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NKG2-A (KLRC1) cytoplasmic domain delivers inhibitory signals to NK cells, while NKG2-C delivers activating signals; the inhibitory function of NKG2-A is mediated through selective recruitment of the tyrosine phosphatase SHP-1 to the NKG2-A/NKR-P1C chimeric receptor.\",\n      \"method\": \"Chimeric receptor transfection into RNK-16 NK cell line, cytolytic activity assay, calcium mobilization assay, immunoprecipitation of SHP-1\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — chimeric receptor functional assay plus SHP-1 co-IP, replicated, 186 citations\",\n      \"pmids\": [\"9103421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD94/NKG2-A (KLRC1) specifically recognizes HLA-E complexed with peptides derived from HLA class I signal sequences; only peptides containing Met at position 2 (residue 4 of the signal sequence) confer resistance to NK-mediated lysis through CD94/NKG2-A recognition.\",\n      \"method\": \"NK cytotoxicity assays with synthetic peptides, antibody blocking with CD94-specific and KIR-specific mAbs, HLA-E surface upregulation assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay with antibody blocking and peptide structure-function analysis, 567 citations\",\n      \"pmids\": [\"9480992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Specific engagement of CD94/NKG2-A (KLRC1) by HLA-E or by anti-NKG2-A mAb induces tyrosine phosphorylation of the NKG2-A subunit and recruitment of SHP-1 phosphatase; this signaling cascade constitutes the molecular mechanism of CD94/NKG2-A-mediated inhibition.\",\n      \"method\": \"mAb cross-linking, Western blot for tyrosine phosphorylation, co-immunoprecipitation of SHP-1, transfection into RBL-2H3 cells, inhibition of Fc-epsilon-RI secretory events\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including phosphorylation, co-IP, heterologous transfection, and functional inhibition, 101 citations\",\n      \"pmids\": [\"9565368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HLA-E-bound peptides influence recognition by inhibitory CD94/NKG2-A (KLRC1) and activating CD94/NKG2-C receptors; the HLA-G-derived nonamer peptide (VMAPRTLFL) engages the activating CD94/NKG2C receptor with significantly higher affinity than the inhibitory CD94/NKG2-A, triggering cytotoxicity.\",\n      \"method\": \"NK clone cytotoxicity assays with 721.221 cells loaded with synthetic leader sequence nonapeptides, HLA-E surface expression analysis\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic peptide panel with NK clones expressing defined receptor isoforms, 311 citations\",\n      \"pmids\": [\"9754572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD94/NKG2-A (KLRC1) has higher binding affinity for HLA-E than the activating CD94/NKG2-C receptor; binding kinetics show very fast association and dissociation rate constants; recognition of HLA-E by both receptors is peptide-dependent with a direct correlation between binding affinity and NK cell response.\",\n      \"method\": \"Surface plasmon resonance (BIAcore) with soluble recombinant HLA-E and CD94/NKG2-A and CD94/NKG2-C proteins\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative binding kinetics with recombinant proteins, rigorous biophysical assay, 298 citations\",\n      \"pmids\": [\"10428963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD94/NKG2-A (KLRC1) inhibitory complex blocks CD16-triggered Syk kinase activation, tyrosine phosphorylation of CD16 zeta subunit, and downstream ERK activation in NK cells; the block operates at a PTK-dependent step by impairing Shc phosphorylation and Shc/Grb-2 complex formation.\",\n      \"method\": \"Co-engagement of CD94/NKG2-A and CD16 by antibody cross-linking, Western blot for Syk and ERK phosphorylation, Shc/Grb-2 co-immunoprecipitation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple signaling pathway components analyzed with orthogonal biochemical assays\",\n      \"pmids\": [\"10358164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD94/NKG2-A (KLRC1) engagement with HLA-E leads to phosphorylation of the CD94/NKG2 complex and recruitment of SHP-1 to the complex, mediating inhibition of xenoreactive NK cells.\",\n      \"method\": \"Antibody blocking assays with F(ab')2 anti-CD94, phosphorylation assay, SHP-1 co-immunoprecipitation in porcine endothelial cell model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical confirmation of SHP-1 recruitment in a xenogeneic system, single lab\",\n      \"pmids\": [\"10570324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The crystal structure of CD94 reveals a novel C-type lectin fold with a non-functional Ca2+-binding site and altered putative carbohydrate-binding site; the CD94 dimer interface reveals a putative HLA-E ligand-binding region and suggests how NKG2 interacts with CD94.\",\n      \"method\": \"X-ray crystallography at 2.6 Å resolution\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure, foundational structural paper, 111 citations\",\n      \"pmids\": [\"10023772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD94/NKG2-A (KLRC1) co-engagement inhibits CD69-triggered ERK activation and NK cell degranulation; specifically, CD94/NKG2-A suppresses ERK activity initiated by CD69, providing molecular evidence for cross-inhibition between activating and inhibitory receptor pathways.\",\n      \"method\": \"RBL cell transfectants expressing both CD69 and CD94/NKG2-A, degranulation assay, ERK phosphorylation Western blot, cytotoxicity assay with anti-NKG2-A blockade\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic signaling assay in transfectants plus primary NK cell confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"10671222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD94/NKG2-C (activating isoform) transduces its triggering signal through the DAP12/KARAP ITAM-bearing adaptor molecule; engagement of CD94/NKG2-C induces MAPK phosphorylation, and the MAPK pathway participates in CD94-dependent TNF-alpha production and cytotoxicity.\",\n      \"method\": \"NK clone activation assays, MEK inhibitor (PD098059), RBL transfection with CD94/NKG2-C/DAP12, calcium mobilization, serotonin release, MAPK phosphorylation\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — heterologous transfection plus pharmacological inhibition with multiple functional readouts\",\n      \"pmids\": [\"11069065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The 2.5 Å crystal structure of CD94-NKG2A heterodimer shows an asymmetric dimer interface that contrasts with homodimeric NK receptors, providing a structural basis for preferred heterodimeric assembly; mutagenesis studies identify CD94 as playing the dominant role in interacting with HLA-E compared to the NKG2A chain.\",\n      \"method\": \"X-ray crystallography at 2.5 Å resolution, structure-based mutagenesis of HLA-E and CD94-NKG2A binding interface\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis validation, 81 citations\",\n      \"pmids\": [\"18083576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Subtle changes in peptide conformation within the HLA-E binding groove—not changes in HLA-E heavy chain conformation—determine differential recognition by CD94-NKG2 receptors; structural comparison of HLA-E/VMAPRALLL (poorly recognized) vs HLA-E/VMAPRTLFL (high affinity CD94-NKG2 ligand) revealed peptide conformation as the discriminating feature.\",\n      \"method\": \"X-ray crystallography of HLA-E/peptide complexes at 2.5 Å resolution\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — dual crystal structures with direct structural comparison, 88 citations\",\n      \"pmids\": [\"18339401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD94/NKG2-A (KLRC1) inhibitory receptor is involved in NK cell recognition of HLA-G1; mAbs against CD94 reconstituted cytolytic activity against HLA-G1-transfected cells, and most NK clones inhibited by HLA-G1 expressed CD94/NKG2-A.\",\n      \"method\": \"NK clone cytotoxicity assays, antibody blocking with CD94- and KIR-specific mAbs, KIR-IgG fusion protein binding assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay with specific antibody blocking, replicated across donors, 109 citations\",\n      \"pmids\": [\"9190923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD94/NKG2-A (KLRC1) is the predominant inhibitory NK receptor for HLA-G used by decidual NK cells; anti-CD94 mAb prevented NK cell recognition of HLA-G transfectants, whereas mAbs against KIR receptors for HLA-C and HLA-B had no effect.\",\n      \"method\": \"NK clone cytotoxicity assays with 721.221 cells transfected with HLA-G, mAb blocking with anti-CD94 and anti-KIR antibodies\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific antibody blocking in primary decidual NK clones, 95 citations\",\n      \"pmids\": [\"9233599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HLA-E is expressed on trophoblast cells, and CD94/NKG2-A (KLRC1) on decidual NK cells binds HLA-E tetrameric complexes; the overall effect of CD94/NKG2 interaction with HLA-E is inhibition of cytotoxicity by decidual NK cells.\",\n      \"method\": \"HLA-E tetramer binding assays, antibody blocking with anti-CD94, cytotoxicity assays with decidual NK cells\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct tetramer binding plus functional cytotoxicity assay with blocking, 290 citations\",\n      \"pmids\": [\"10898498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD94/NKG2-A (KLRC1) inhibitory receptor modulates anti-viral and anti-tumoral responses of Vgamma9Vdelta2 T cells; anti-CD94 mAb inhibits Vgamma9Vdelta2 T cell proliferation, IFN-gamma and TNF-alpha synthesis, and cytotoxic activity.\",\n      \"method\": \"Cytokine production assays, proliferation assays, cytotoxicity assays with anti-CD94 mAb blocking\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional blocking assay but indirect (antibody against CD94 subunit), single lab, 129 citations\",\n      \"pmids\": [\"9550399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In the absence of DAP12, NKG2A (KLRC1) is preferentially expressed at the cell surface with CD94 over NKG2C due to a single amino acid difference in the transmembrane domain; DAP12 co-expression enhances NKG2C's ability to compete for cell surface CD94 heterodimerization.\",\n      \"method\": \"Transfection of rhesus monkey NKG2A and NKG2C into COS cells with and without DAP12, flow cytometry for cell surface expression, chimeric receptor constructs\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transfection-based mapping of transmembrane domain determinants for heterodimerization, single lab\",\n      \"pmids\": [\"15153509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The CD94/NKG2A (KLRC1) inhibitory receptor plays a critical role in down-regulating iNKT cell responses; IFN-gamma upregulates Qa-1b (murine HLA-E homolog) expression which in turn inhibits iNKT cell activity via CD94/NKG2A interaction; blockade of CD94/NKG2-Qa-1b interaction augments recall responses.\",\n      \"method\": \"Mouse iNKT cell stimulation with alpha-GalCer/OCH, antibody blockade of CD94/NKG2 interaction, cytokine measurement, genetic epistasis with Qa-1b\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional epistasis with blocking antibody in mouse model, 45 citations\",\n      \"pmids\": [\"15746081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IL-12 induces expression of NKG2-A (KLRC1) and CD94 on CD8+ T cells, and IL-12-induced expression of both subunits leads to acquisition of a functional inhibitory receptor as demonstrated in redirected killing assays; this induction was not mediated by IFN-gamma or IL-15.\",\n      \"method\": \"Cytokine stimulation of T cells, flow cytometry, redirected killing assay, RT-PCR\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cytokine induction coupled to functional receptor assay, single lab, 57 citations\",\n      \"pmids\": [\"11994435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD94/NKG2 (KLRC1 product) expressed on microglial cells interacts with Qa-1 (murine HLA-E homolog) expressed in layer 6 cortical neurons to regulate activity-dependent ocular dominance plasticity; selectively targeting the Qa-1/CD94/NKG2 interaction phenocopies plasticity perturbation seen in Qa-1 knockout mice.\",\n      \"method\": \"Mouse genetic knockout (Qa-1 KO), pharmacological blockade of Qa-1/CD94-NKG2 interaction, ocular dominance plasticity assay, microglial morphology analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with receptor blockade establishing functional pathway in a novel cellular context, 12 citations\",\n      \"pmids\": [\"35648829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLRC1 knockout in human NK cells eliminates NKG2A surface expression and overcomes HLA-E-mediated inhibition of NK cytotoxicity against solid tumor cell lines; KLRC1 KO NK cells showed significantly higher cytotoxicity against HLA-E+ tumor lines and delayed tumor progression in a xenograft mouse model; NKG2C expression was increased in KLRC1 KO NK cells.\",\n      \"method\": \"CRISPR-mediated KLRC1 gene editing, in vitro cytotoxicity assays against multiple tumor lines, xenogeneic mouse model of HLA-E+ metastatic breast cancer\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined phenotypic readout in vitro and in vivo, multiple tumor lines tested\",\n      \"pmids\": [\"37675109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LAG-3 sustains a CD94/NKG2+ subset of exhausted CD8 T cells with enhanced cytotoxicity mediated by recognition of the stress ligand Qa-1b; loss of LAG-3 reduces this CD94/NKG2+ Tex subset, demonstrating a LAG-3-dependent circuit for NKG2 expression in T cell exhaustion.\",\n      \"method\": \"Genetic loss-of-function (LAG-3 KO), chronic viral infection mouse model, single-cell analysis, in vitro functional assays with Qa-1b blocking\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis plus functional validation in vivo and in vitro, 76 citations\",\n      \"pmids\": [\"39121847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Antigen-specific NK cell memory against HIV and influenza is largely dependent on the activating CD94/NKG2C receptor and its ligand HLA-E; individual memory NK cells permanently acquired antigen specificity (validated by single-cell cloning), and individual HLA-E-restricted peptides constitute dominant NK cell responses in vivo.\",\n      \"method\": \"Single-cell cloning of memory NK cells, complex immunophenotyping, HLA-E peptide stimulation assays, functional memory assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell cloning with functional validation establishing antigen specificity via CD94/NKG2C-HLA-E axis\",\n      \"pmids\": [\"38064568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Among 16 common classical HLA class I signal peptide (SP) variants, only 6 'functional SPs' efficiently generate epitopes enabling CD94/NKG2 engagement with HLA-E; HLA-B/-21M SP induces high HLA-E expression but provides the lowest receptor recognition and competes with other SPs, reducing overall CD94/NKG2A recognition of target cells.\",\n      \"method\": \"Systematic quantitative peptide-HLA-E binding assays, CD94/NKG2 receptor recognition functional assays, genetic population analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — systematic quantitative approach with multiple orthogonal functional assays, 49 citations\",\n      \"pmids\": [\"37264229\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KLRC1 encodes NKG2A, which forms a disulfide-linked heterodimer with CD94 on NK and T cells; this CD94/NKG2A complex functions as an inhibitory receptor that recognizes HLA-E loaded with HLA class I signal sequence-derived nonapeptides, triggering ITIM-mediated recruitment of SHP-1 phosphatase to tyrosine-phosphorylated NKG2A, which then blocks downstream Syk and ERK activation to suppress NK cytotoxicity, while the activating paralogue NKG2C (in the CD94/NKG2C heterodimer coupled to DAP12) delivers opposite signals—with CD94 playing the dominant role in HLA-E contact as revealed by crystal structures of the CD94-NKG2A/HLA-E axis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KLRC1 encodes NKG2A, a type II transmembrane C-type lectin-domain protein that forms a disulfide-linked inhibitory heterodimer with CD94 on NK cells, CD8+ T cells, γδ T cells, and iNKT cells, serving as a central checkpoint receptor that monitors HLA class I expression through recognition of HLA-E loaded with signal-sequence-derived nonapeptides [PMID:2007850, PMID:8943374, PMID:9480992]. Ligand engagement induces tyrosine phosphorylation of the NKG2A ITIM motifs and recruitment of the SHP-1 phosphatase, which blocks proximal signaling through Syk, ERK, and Shc/Grb-2, thereby suppressing cytotoxicity and cytokine production [PMID:9103421, PMID:9565368, PMID:10358164]. The CD94/NKG2A heterodimer binds HLA-E with higher affinity than its activating counterpart CD94/NKG2C, with peptide conformation within the HLA-E groove—rather than heavy-chain differences—determining differential receptor engagement, and CD94 contributing the dominant ligand-contact surface as revealed by crystal structures [PMID:10428963, PMID:18083576, PMID:18339401]. Beyond canonical immune surveillance, this receptor axis operates in decidual NK cell tolerance to trophoblast HLA-E, in LAG-3-dependent exhausted CD8+ T cell subsets during chronic viral infection, and in microglial regulation of ocular dominance plasticity [PMID:10898498, PMID:39121847, PMID:35648829].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Molecular cloning established that KLRC1 encodes a novel NK-cell-expressed type II membrane protein with a C-type lectin domain, revealing the gene's identity and basic structural architecture.\",\n      \"evidence\": \"cDNA library screening and full-length sequencing from an NK cell line\",\n      \"pmids\": [\"2007850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand unknown\", \"Signaling function unknown\", \"Heterodimeric partner not yet identified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Biochemical studies revealed that NKG2A obligately heterodimerizes with CD94 via disulfide bonds and that its cytoplasmic ITIMs provide the structural basis for inhibitory signaling, resolving how the receptor complex assembles and predicting its inhibitory function.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation and ITIM motif identification across multiple labs\",\n      \"pmids\": [\"8943374\", \"9045931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand identity still unknown\", \"ITIM-dependent phosphatase recruitment not yet demonstrated\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Chimeric receptor assays and functional studies identified SHP-1 phosphatase recruitment to phosphorylated NKG2A as the proximal mechanism of inhibition, and demonstrated that HLA-E (loaded with HLA class I signal peptides) is the ligand—with CD94/NKG2A also mediating inhibition of decidual NK killing of HLA-G-expressing trophoblast via HLA-E.\",\n      \"evidence\": \"Chimeric receptor transfection with SHP-1 co-IP; NK cytotoxicity assays with synthetic peptides and anti-CD94 blocking; decidual NK clone assays\",\n      \"pmids\": [\"9103421\", \"9480992\", \"9190923\", \"9233599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative binding affinity not measured\", \"Structural basis of HLA-E recognition unknown\", \"Downstream signaling cascade beyond SHP-1 not mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Ligand engagement was shown to induce NKG2A tyrosine phosphorylation and SHP-1 recruitment in intact cells, confirming the ITIM→SHP-1 model; peptide selectivity studies revealed that peptide conformation within HLA-E governs differential recognition by inhibitory NKG2A versus activating NKG2C.\",\n      \"evidence\": \"Cross-linking, phosphorylation assays, heterologous RBL transfectants; NK clones with systematic peptide panels\",\n      \"pmids\": [\"9565368\", \"9754572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding kinetics not quantified\", \"No structural explanation for peptide discrimination\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Biophysical measurements established that CD94/NKG2A binds HLA-E with higher affinity than CD94/NKG2C, explaining how the inhibitory receptor dominates under physiological conditions; signaling studies mapped the downstream inhibitory cascade to blockade of Syk, ERK, and Shc/Grb-2 pathways.\",\n      \"evidence\": \"Surface plasmon resonance with recombinant proteins; antibody co-crosslinking with Western blot for Syk, ERK, Shc phosphorylation\",\n      \"pmids\": [\"10428963\", \"10358164\", \"10023772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal of CD94/NKG2A with HLA-E\", \"Structural basis for affinity difference between NKG2A and NKG2C unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"CD94/NKG2A was shown to cross-inhibit activating receptors including CD69-triggered ERK signaling, and HLA-E tetramer binding confirmed the pathway operates in decidual NK cells to maintain fetal tolerance.\",\n      \"evidence\": \"RBL transfectants co-expressing CD69 and CD94/NKG2A with ERK and degranulation assays; HLA-E tetramer staining of decidual NK cells\",\n      \"pmids\": [\"10671222\", \"10898498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of CD94/NKG2A versus KIR to maternal-fetal tolerance not resolved\", \"In vivo relevance in human pregnancy not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Transmembrane domain determinants were found to explain preferential surface expression of NKG2A over NKG2C in the absence of DAP12, providing a mechanism for default inhibitory bias at the cell surface.\",\n      \"evidence\": \"Transfection of NKG2A/NKG2C chimeras into COS cells ± DAP12, flow cytometry\",\n      \"pmids\": [\"15153509\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Study used rhesus monkey sequences; human equivalence assumed but not directly tested\", \"Quantitative stoichiometry on primary human NK cells not determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The crystal structure of the CD94–NKG2A heterodimer revealed an asymmetric interface and mutagenesis identified CD94 as the dominant HLA-E-contacting subunit, answering how the two chains divide labor in ligand recognition.\",\n      \"evidence\": \"X-ray crystallography at 2.5 Å with structure-guided mutagenesis\",\n      \"pmids\": [\"18083576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full ternary complex structure (CD94/NKG2A bound to HLA-E/peptide) not yet solved at this point\", \"How NKG2A ITIM accessibility changes upon ligand binding structurally unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Comparative crystallography of HLA-E with different peptides showed that subtle peptide conformational changes—not HLA-E heavy chain rearrangements—govern differential CD94/NKG2 recognition, explaining peptide-dependent selectivity at atomic resolution.\",\n      \"evidence\": \"Dual crystal structures of HLA-E/peptide complexes at 2.5 Å\",\n      \"pmids\": [\"18339401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ternary complex with receptor still not captured crystallographically\", \"Dynamic aspects of peptide-dependent discrimination not addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The Qa-1/CD94/NKG2 axis was discovered to operate in microglia regulating neuronal ocular dominance plasticity, extending the receptor's functional role far beyond classical immune surveillance.\",\n      \"evidence\": \"Qa-1 knockout mice and pharmacological blockade of CD94/NKG2 in ocular dominance plasticity assays\",\n      \"pmids\": [\"35648829\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Human relevance not established\", \"Whether this involves NKG2A (inhibitory) or NKG2C (activating) signaling in microglia not distinguished\", \"Downstream microglial effector mechanisms unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CRISPR knockout of KLRC1 in human NK cells eliminated HLA-E-mediated inhibition and enhanced anti-tumor cytotoxicity in vivo, validating NKG2A as a non-redundant immune checkpoint; concurrently, systematic analysis of HLA class I signal peptides showed only 6 of 16 variants efficiently engage CD94/NKG2A through HLA-E, revealing population-level heterogeneity in checkpoint strength.\",\n      \"evidence\": \"KLRC1 CRISPR KO NK cells in xenograft breast cancer model; quantitative peptide-HLA-E binding and receptor recognition assays across 16 signal peptide variants\",\n      \"pmids\": [\"37675109\", \"37264229\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Clinical translation of KLRC1 KO NK cell therapy not validated\", \"How signal peptide competition shapes individual immune responses in vivo not fully modeled\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"LAG-3 was found to sustain a CD94/NKG2-expressing subset of exhausted CD8+ T cells with enhanced cytotoxicity via Qa-1b recognition, revealing a regulatory circuit that links T cell exhaustion programs to NKG2 receptor expression.\",\n      \"evidence\": \"LAG-3 KO in chronic LCMV infection model with single-cell profiling and Qa-1b blocking\",\n      \"pmids\": [\"39121847\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LAG-3 regulates NKG2A versus NKG2C specifically in this context not resolved\", \"Human correlate of LAG-3/NKG2 axis in chronic infection or cancer not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full ternary crystal structure of CD94/NKG2A bound to HLA-E/peptide, the conformational dynamics linking ligand engagement to ITIM phosphorylation, how NKG2A versus NKG2C expression is regulated at the transcriptional level in different lymphocyte subsets, and whether the neuroimmune functions of this axis operate through canonical ITIM/SHP-1 signaling.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No ternary co-crystal structure of CD94/NKG2A/HLA-E/peptide published\", \"Transcriptional regulation of KLRC1 in different cell lineages poorly defined\", \"Mechanism of NKG2A function in microglia not molecularly characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 3, 5, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 8, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 2, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 4, 5, 8, 11, 23, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 5, 8, 11, 12]}\n    ],\n    \"complexes\": [\n      \"CD94/NKG2A heterodimer\"\n    ],\n    \"partners\": [\n      \"CD94\",\n      \"SHP-1\",\n      \"HLA-E\",\n      \"DAP12\",\n      \"NKG2C\",\n      \"LAG-3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}